Greenphire Named One of the Fastest-Growing U.S Companies
News Aug 21, 2013
The company has been ranked 192, and 21 in the software industry, on the seventh annual list which represents the most comprehensive look at America's independent entrepreneurs.
Sam Whitaker, CEO, Greenphire, comments: "We are delighted to have made this year's Inc. 500. The Greenphire team has worked relentlessly to achieve our success and we are proud to have joined the ranks with many of the nation's most high achieving and innovative companies."
Since Greenphire was founded in 2008, the business has gone from strength-to-strength, launching two groundbreaking clinical payment technologies and securing contracts with multiple top 30 pharmaceutical companies. In the past 12 months alone, Greenphire has more than doubled its team and has established strategic partnerships with a number of leading organizations.
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Alzheimer’s Drug Discovery Foundation Announces $1.8M in New FundingNews
The Alzheimer’s Drug Discovery Foundation (ADDF) announces nearly $1.8 million in new funding, which reflects a commitment to advancing drugs in or near human clinical trials. All five funded programs are potential treatments for Alzheimer’s disease and other forms of dementia.READ MORE
New Research Hub to Tackle Global Vaccination ChallengesNews
The University of Bristol will contribute to a new research hub to increase global immunisation coverage and improve response to viral outbreaks through the rapid and cost-effective deployment of vaccines.READ MORE